Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Sprangers

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
Kidney International Reports|July 9, 2025
Identification and Cross-Platform Validation of Sparse Molecular Classifiers for Antibody-Mediated and T-Cell-Mediated Rejection After Kidney TransplantationJasper Callemeyn, Josué Manik Nava-Sedeño, Dany Anglicheau, et al.
Nature Communications|July 19, 2023
Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejectionBaptiste Lamarthée, Jasper Callemeyn, Yannick Van Herck, et al.
Journal for Immunotherapy of Cancer|September 22, 2022
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKIShruti Gupta, Clara Garcia-Carro, Jason M Prosek, et al.
Eclinicalmedicine|April 28, 2025
Aligning kidney function assessment in patients with cancer to global practices in internal medicineGeeta Sandhu, Josephine Adattini, Evangeline Armstrong Gordon, et al.
Nature Reviews. Nephrology|December 9, 2025
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroupAmanda DeMauro Renaghan, Marlies Ostermann, Claudio Ronco, et al.
Eclinicalmedicine|April 28, 2025
Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practiceGeeta Sandhu, Josephine Adattini, Evangeline Armstrong Gordon, et al.
Kidney International|August 14, 2022
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancerShruti Gupta, Ian A Strohbehn, Qiyu Wang, et al.
The Journal of Clinical Investigation|August 8, 2024
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injuryShruti Gupta, Olivia Green-Lingren, Sudhir Bhimaniya, et al.
Kidney International|December 28, 2020
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplantNaoka Murakami, Patrick Mulvaney, Melissa Danesh, et al.
Journal for Immunotherapy of Cancer|October 9, 2021
Acute kidney injury in patients treated with immune checkpoint inhibitorsShruti Gupta, Samuel A P Short, Meghan E Sise, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Kidney International Reports|July 9, 2025
Identification and Cross-Platform Validation of Sparse Molecular Classifiers for Antibody-Mediated and T-Cell-Mediated Rejection After Kidney TransplantationJasper Callemeyn, Josué Manik Nava-Sedeño, Dany Anglicheau, et al.
Nature Communications|July 19, 2023
Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejectionBaptiste Lamarthée, Jasper Callemeyn, Yannick Van Herck, et al.
Journal for Immunotherapy of Cancer|September 22, 2022
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKIShruti Gupta, Clara Garcia-Carro, Jason M Prosek, et al.
Eclinicalmedicine|April 28, 2025
Aligning kidney function assessment in patients with cancer to global practices in internal medicineGeeta Sandhu, Josephine Adattini, Evangeline Armstrong Gordon, et al.
Nature Reviews. Nephrology|December 9, 2025
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroupAmanda DeMauro Renaghan, Marlies Ostermann, Claudio Ronco, et al.
Eclinicalmedicine|April 28, 2025
Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practiceGeeta Sandhu, Josephine Adattini, Evangeline Armstrong Gordon, et al.
Kidney International|August 14, 2022
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancerShruti Gupta, Ian A Strohbehn, Qiyu Wang, et al.
The Journal of Clinical Investigation|August 8, 2024
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injuryShruti Gupta, Olivia Green-Lingren, Sudhir Bhimaniya, et al.
Kidney International|December 28, 2020
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplantNaoka Murakami, Patrick Mulvaney, Melissa Danesh, et al.
Journal for Immunotherapy of Cancer|October 9, 2021
Acute kidney injury in patients treated with immune checkpoint inhibitorsShruti Gupta, Samuel A P Short, Meghan E Sise, et al.
Pageof 19